The purpose of this study is to determine whether treatment with Symbicort for 12 weeks will
improve lung function and symptoms of adults and adolescents with asthma.
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Budesonide Budesonide, Formoterol Fumarate Drug Combination Formoterol Fumarate